Drug-resistant epilepsy: what comes after medication trials?
When seizures continue despite appropriately chosen medicines, a comprehensive epilepsy review can uncover further options. Assessment may lead to a revised medication plan, surgery, a stimulation device or specialist dietary treatment.
On this page
What drug-resistant epilepsy means
The International League Against Epilepsy defines drug resistance around failure of two appropriately chosen, tolerated and adequately used medication schedules to achieve sustained seizure freedom. The schedules may involve one medicine or a combination.
Simply counting drug names can be misleading. A medicine abandoned very early because of intolerance may not provide the same information as an adequate trial. For each treatment, record the dose reached, duration, seizures during treatment and reason it ended. That history helps the specialist decide what has actually been tested.
Sources and references: [1]
Recheck the diagnosis and the treatment history
A specialist review asks whether all the recorded events are epileptic seizures, whether the seizure type has been correctly identified and whether the medicines matched it. Missed doses, interactions or an incomplete treatment trial may also change the interpretation.
Bring a seizure diary and, when it can be obtained safely, a video of a typical event. Include the earlier EEG and MRI reports and the images themselves. Different event types should be described separately rather than combined into one monthly total.
A comprehensive assessment is useful before choosing a procedure
Referral to an epilepsy center opens a wider treatment discussion. It does not commit the patient to surgery. The team may review imaging, arrange further seizure recording and assess how epilepsy affects learning, memory, mood and daily life.
Prepare the questions that matter at home: whether a child can attend school consistently, whether injuries are increasing or whether medication side effects are limiting work. These concerns help set priorities. Our separate pediatric presurgical guide explains video-EEG and the assessment process in more detail.
Sources and references: [3]
When surgery may be considered
Surgery may be considered when the team can identify a seizure-generating area and judge that treatment can be undertaken with an acceptable effect on important brain functions. The operation and its aims depend on the individual findings.
Discuss the expected chance of seizure control alongside possible effects on memory, language, movement or vision. Ask which risks are specific to the proposed brain area and how they would affect school, work or valued activities. The decision should include the likely course of continued seizures as well as the risks of an operation.
Sources and references: [3]
Devices and dietary treatment have different roles
Vagus nerve stimulation is one option when medication alone is insufficient. It uses an implanted device to help reduce seizures and requires follow-up. It should be discussed in terms of the intended improvement and the treatment that will continue alongside it.
A ketogenic dietary treatment may also be considered, particularly in selected childhood epilepsies. This is a specialist treatment requiring clinical and dietetic supervision, not a diet to start from an online recipe. Ask how growth, nutrition and tolerability will be monitored and who will support the family between appointments.
Sources and references: [2]
Keep everyday safety in the plan
A written seizure action plan helps family, carers and school staff know what to do. It should cover rescue treatment where prescribed and when emergency help is needed. Prolonged seizures or repeated seizures without recovery need urgent attention.
Medication changes should be supervised. If pregnancy is planned or possible, raise it early because some antiseizure medicines carry reproductive risks and a planned review is important. For children, make sure the plan can be followed by everyone providing care, including during travel and at school.
Sources and references: [2]
Preparing a child for a Shanghai review
Children's Hospital of Fudan University has pediatric neurological and rare-disease expertise. A referral enquiry should describe the child's age, seizure pattern, developmental history and treatments already tried, so it reaches the appropriate team.
EastMedGo can organize those records, identify missing EEG or imaging files and help clarify the proposed assessment sequence. We can also help the family ask about the expected visit length and how care will continue at home. The first useful outcome is a clear explanation of the next decision, even when further testing is needed before a procedure can be discussed.
Sources and references: [4]
Common questions
Does drug resistance mean that no treatment can help?
No. It means appropriately used medicines have not achieved sustained seizure freedom under the accepted definition. A comprehensive review can consider further medication strategies and non-drug options.
Should every patient with drug-resistant epilepsy have surgery?
No. Specialist assessment determines whether a suitable surgical target exists and weighs the likely benefit against functional risks. Other treatment routes may be more appropriate.
Sources and references: [3]
Can we stop medicines while arranging an overseas assessment?
Continue the prescribed regimen unless the treating clinician changes it. Bring the current schedule and seizure action plan, and arrange enough medication for the assessment and journey.
Sources and references: [2]
Sources and references
- ILAE: Definition of drug-resistant epilepsy consensus proposal
- NHS: Epilepsy
- ILAE: Improving the epilepsy surgery evaluation pipeline
- Fudan University: Professor Wang Yi and pediatric neurology expertise
Prepared with AI assistance by EastMedGo for patients comparing treatment and care options.